Product NDC: | 53808-0364 |
Proprietary Name: | Doxazosin |
Non Proprietary Name: | DOXAZOSIN MESYLATE |
Active Ingredient(s): | 4 mg/1 & nbsp; DOXAZOSIN MESYLATE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 53808-0364 |
Labeler Name: | State of Florida DOH Central Pharmacy |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075580 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090701 |
Package NDC: | 53808-0364-1 |
Package Description: | 30 TABLET in 1 BLISTER PACK (53808-0364-1) |
NDC Code | 53808-0364-1 |
Proprietary Name | Doxazosin |
Package Description | 30 TABLET in 1 BLISTER PACK (53808-0364-1) |
Product NDC | 53808-0364 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DOXAZOSIN MESYLATE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090701 |
Marketing Category Name | ANDA |
Labeler Name | State of Florida DOH Central Pharmacy |
Substance Name | DOXAZOSIN MESYLATE |
Strength Number | 4 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |